Soleno Therapeutics (SLNO) Retained Earnings: 2013-2019
Historic Retained Earnings for Soleno Therapeutics (SLNO) over the last 5 years, with Sep 2019 value amounting to -$143.2 million.
- Soleno Therapeutics' Retained Earnings fell 12.48% to -$143.2 million in Q3 2019 from the same period last year, while for Sep 2019 it was -$143.2 million, marking a year-over-year decrease of 12.48%. This contributed to the annual value of -$127.0 million for FY2018, which is 11.73% down from last year.
- Per Soleno Therapeutics' latest filing, its Retained Earnings stood at -$143.2 million for Q3 2019, which was up 0.62% from -$144.1 million recorded in Q2 2019.
- In the past 5 years, Soleno Therapeutics' Retained Earnings ranged from a high of -$80.1 million in Q2 2015 and a low of -$144.1 million during Q2 2019.
- In the last 3 years, Soleno Therapeutics' Retained Earnings had a median value of -$124.6 million in 2018 and averaged -$122.4 million.
- Data for Soleno Therapeutics' Retained Earnings shows a maximum YoY tumbled of 32.13% (in 2015) over the last 5 years.
- Quarterly analysis of 5 years shows Soleno Therapeutics' Retained Earnings stood at -$86.2 million in 2015, then declined by 13.99% to -$98.3 million in 2016, then decreased by 15.65% to -$113.7 million in 2017, then dropped by 11.73% to -$127.0 million in 2018, then declined by 12.48% to -$143.2 million in 2019.
- Its last three reported values are -$143.2 million in Q3 2019, -$144.1 million for Q2 2019, and -$134.1 million during Q1 2019.